 ABO antigens microglobulin transitional cell carcinoma Predictors response intravesical bacillus Calmette-Guerin response patients superficial transitional cell carcinoma bladder STCB intravesical chemotherapy variable patients long period recurrence others recurrence tumor years removal primary lesion others loss normal cell surface antigens ABO blood group microglobulin aggressive behavior tumor study immunohistochemical techniques authors initial pretreatment biopsy specimen bladder tumors presence ABO antigens Data sample patient population biopsy-proven STCB expression markers predictive therapeutic response prophylactic intravesical bacillus Calmette-Guerin BCG Tice strain resection expression markers predictive value expression antigen